Syngenta v. UPL Limited: Fungicide Patent Case Transferred to Richmond Division
Syngenta Crop Protection AG filed suit against UPL Limited alleging infringement of two patents covering its Elatus®, Mitrion™, and Solatenol® (benzovindiflupyr) fungicide technology. The Virginia Eastern District Court transferred the case intradistrict to the Richmond Division on the same day it was filed, reassigned as Case No. 3:25cv735.
Syngenta Targets UPL Over Benzovindiflupyr Fungicide Patents
Syngenta Crop Protection AG, the Swiss agrochemical giant, filed this infringement action against UPL Limited in the Virginia Eastern District Court on September 11, 2025. The complaint asserts two U.S. patents — US12402625B2 (application no. US17/130193) and US11445727B2 (application no. US16/347283) — covering fungicide technology commercialised under Syngenta’s Elatus®, Mitrion™, and Solatenol® (benzovindiflupyr) product lines. UPL Limited, a major global agrochemical company, is alleged to have infringed these assets, which sit at the core of Syngenta’s SDHI fungicide portfolio.
On the same day the complaint was filed, the court issued an intradistrict transfer to the Richmond Division, reassigning the matter as Case No. 3:25cv735. This administrative transfer does not reflect any ruling on the merits; both patents remain fully asserted and the case proceeds before a Richmond-based judge. The basis of termination for this docket entry is recorded simply as ‘Case Transferred,’ meaning no substantive adjudication has occurred under Case No. 1:25-cv-01520.
The same-day transfer strongly suggests a clerical or divisional assignment determination rather than any contested motion. Intradistrict transfers of this kind typically reflect local rules on proper division assignment within the district. The substantive litigation — including claim construction, infringement analysis, and any validity challenges UPL may raise — will unfold under the Richmond docket. The public record for this docket is silent on defendant representation, claim specifics, and damages sought at this stage.
Filing to Case Transferred in 0 days
Case filed and transferred within the same day — unusually swift administrative reassignment
Intradistrict transfer to Richmond: what this means for both parties
What an intradistrict transfer means for this case
An intradistrict transfer moves a case between divisions within the same federal district court — here from the Alexandria Division to the Richmond Division of the Eastern District of Virginia. It does not dismiss the action, trigger any statute of limitations issues, or reflect any ruling on the merits. All pleadings, rights, and pending obligations carry over automatically to the new case number (3:25cv735).
Case continues in RichmondRichmond Division: a different judicial environment
The Eastern District of Virginia’s Richmond Division is known for its brisk docket management, comparable to the district’s reputation as the ‘Rocket Docket.’ Patent litigants assigned to Richmond should anticipate compressed scheduling orders, limited discovery extensions, and early claim construction proceedings. For Syngenta, this may accelerate time to trial; for UPL, rapid engagement on invalidity and non-infringement positions will be essential from the outset.
Accelerated docket expectedLitigation proceeds under Case No. 3:25cv735
All future substantive activity — defendant’s response or motion to dismiss, Markman hearing scheduling, discovery, and any IPR or PGR petitions at the USPTO — will be tracked under the Richmond docket number 3:25cv735. Practitioners monitoring this dispute should update their docket alerts accordingly. No judge assignment is recorded in the transferred docket at this stage, so tracking the Richmond filing is critical for current procedural status.
Monitor docket 3:25cv735High-stakes SDHI fungicide IP at the centre of this dispute
Benzovindiflupyr (the active ingredient in Solatenol® and Elatus®) is a leading SDHI fungicide with significant global market value. A finding of infringement could restrict UPL’s ability to market competing formulations in the U.S. market. Competitors and generic agrochemical manufacturers in the SDHI space should monitor this case closely, as claim scope determinations will have broad freedom-to-operate implications across the sector.
SDHI fungicide FTO riskFull party and counsel information
| Role | Name | Type | Detail |
|---|---|---|---|
| Plaintiff | Syngenta Crop Protection AG | Company | Global agrochemical company — holder of US12402625B2 and US11445727B2 (Solatenol® / benzovindiflupyr)Search in Eureka ↗ |
| Defendant | UPL Limited | Individual | UPL Limited — global agrochemical and crop protection company alleged to infringe Syngenta’s fungicide patentsSearch in Eureka ↗ |
| Plaintiff counsel | Charles C. Carson | Attorney | Counsel for Syngenta Crop Protection AGSearch in Eureka ↗ |
| Plaintiff law firm | Baker & Hostetler, LLP | Law Firm | Representing Syngenta Crop Protection AGSearch in Eureka ↗ |
| Presiding judge | Judge N/A | Judge | Virginia Eastern District CourtSearch in Eureka ↗ |
Official order — verbatim text
The verdict notation records an intradistrict transfer to the Richmond Division with reassignment to Case No. 3:25cv735. This is a purely administrative disposition — no infringement finding, no validity ruling, and no damages assessment has been made. The phrasing confirms only that the Alexandria Division docket is closed for administrative purposes; the substantive infringement claims under US12402625B2 and US11445727B2 remain fully live and will be adjudicated in Richmond.
US12402625B2 & US11445727B2 — Benzovindiflupyr SDHI Fungicide Technology
US12402625B2 (application US17/130193) and US11445727B2 (application US16/347283) both relate to Syngenta’s proprietary benzovindiflupyr chemistry — the SDHI (succinate dehydrogenase inhibitor) active ingredient at the heart of its Elatus®, Mitrion™, and Solatenol® fungicide portfolio. SDHI fungicides target fungal respiration at the mitochondrial level, offering broad-spectrum disease control. The differing application dates suggest a continuation or family relationship, providing layered coverage across compositions and methods of use.
Benzovindiflupyr is a high-value asset in the crop protection market, with Solatenol® deployed globally in cereals, soybeans, and specialty crops. The assertion of both patents against UPL — a company with its own extensive agrochemical portfolio — suggests Syngenta believes UPL’s products or active ingredient formulations directly overlap with its protected claims. For any agrochemical company developing or registering SDHI-class fungicides in the U.S., these patents represent a significant clearance risk that demands proactive FTO analysis.
Should your team run an FTO against US12402625B2 and US11445727B2?
Any company formulating, importing, or distributing SDHI fungicides — particularly those containing benzovindiflupyr or structurally related active ingredients — should treat these two Syngenta patents as high-priority FTO targets. The filing of this suit against a major global player like UPL signals that Syngenta is actively monitoring the competitive landscape and prepared to enforce broadly. Registration-stage analysis is no longer sufficient; claim-level clearance is essential.
PatSnap Eureka’s FTO Search Agent can map the full claim scope of US12402625B2 and US11445727B2 against your compound structures, formulations, and application methods — identifying overlap, design-around opportunities, and prior art relevant to validity challenges. With a Richmond trial potentially approaching, building your FTO file now is materially more valuable than waiting for claim construction.
Run a freedom-to-operate analysis on US12402625B2 to assess your product’s exposure
Run FTO in Eureka →Similar SDHI Fungicide Patent Infringement Cases in U.S. District Courts
Explore related agrochemical and SDHI fungicide patent infringement actions litigated in the Eastern District of Virginia and comparable U.S. federal courts.
What this case signals for the agrochemical fungicide IP landscape
Syngenta’s assertive filing against UPL reflects the intensifying patent battleground over next-generation SDHI fungicide chemistry.
SDHI fungicide patents are becoming prime litigation targets
The SDHI class — including benzovindiflupyr — represents billions in global crop protection revenue. Syngenta’s decision to assert both a recent grant (US12402625B2) and an earlier validated patent (US11445727B2) against UPL signals a layered enforcement strategy designed to maximise claim coverage and deter generic entry across multiple product lines.
Same-day transfer suggests swift docket management ahead
The immediate intradistrict reassignment to Richmond Division is consistent with the Eastern District of Virginia’s reputation for tight case management. Both parties should expect an aggressive scheduling order and early substantive deadlines once the Richmond docket is activated. Delayed defendant engagement risks default or waiver of key procedural rights.
Syngenta v UPL — key questions answered
Case No. 1:25-cv-01520 was closed on September 11, 2025 — the same day it was filed — due to an intradistrict transfer to the Richmond Division of the Eastern District of Virginia. The case continues as Case No. 3:25cv735. No merits ruling has been issued.
Syngenta asserted US12402625B2 (application no. US17/130193) and US11445727B2 (application no. US16/347283). Both patents relate to benzovindiflupyr SDHI fungicide technology commercialised under Syngenta’s Elatus®, Mitrion™, and Solatenol® product lines.
An intradistrict transfer moves the case between divisions within the same federal district — here from Alexandria to Richmond. The action does not restart; all claims, parties, and rights carry over. The substantive infringement dispute will proceed before the Richmond Division under Case No. 3:25cv735. No merits determination was made in connection with the transfer.
The products identified in the complaint are Syngenta’s Elatus®, Mitrion™, and Solatenol® (benzovindiflupyr) fungicides. Benzovindiflupyr is an SDHI-class active ingredient used in broad-spectrum cereal, soybean, and specialty crop disease management. UPL is alleged to infringe Syngenta’s patents through competing products or formulations.
The Eastern District of Virginia — including its Richmond Division — is known for efficient case management and relatively fast trial timelines compared to many other U.S. patent litigation venues. Parties litigating before this court typically face compressed discovery schedules and early claim construction hearings, which can materially affect litigation strategy for both patent holders and accused infringers.
PatSnap Eureka searches patents and litigation data to answer instantly.